KT-301
Cell therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jun 30, 2021 (NCT04913272)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05407389 | Phase 2/Phase 3 (Phase 3) | Apr 21, 2022 | Kibow Biotech Inc. |
| NCT04913272 | Phase 2 | Jun 30, 2021 | Kibow Biotech Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kibow Biotech Inc. | For profit | 2 | 2 | 2 | 2021 |
1 organizations
Page 1 / 1